These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 18691382

  • 1. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C, Lee SJ.
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [Abstract] [Full Text] [Related]

  • 2. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A, Rota D, Debetto P, Peroni D, Guidolin D, Negro A, Skaper SD, Giusti P.
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [Abstract] [Full Text] [Related]

  • 3. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK, Wong AK, Lee YW, Wan OW, Chan HY, Chung KK.
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM, Trojanowski JQ.
    Neuron; 2006 Oct 05; 52(1):33-8. PubMed ID: 17015225
    [Abstract] [Full Text] [Related]

  • 5. Alpha-synuclein and Parkinson's disease: a proteomic view.
    Fasano M, Lopiano L.
    Expert Rev Proteomics; 2008 Apr 05; 5(2):239-48. PubMed ID: 18466054
    [Abstract] [Full Text] [Related]

  • 6. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
    Chiba-Falek O, Lopez GJ, Nussbaum RL.
    Mov Disord; 2006 Oct 05; 21(10):1703-8. PubMed ID: 16795004
    [Abstract] [Full Text] [Related]

  • 7. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW, Brundin P.
    Mov Disord; 2013 Jan 05; 28(1):31-40. PubMed ID: 23390095
    [Abstract] [Full Text] [Related]

  • 8. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H, Wu YC, Nakamura M, Liang Y, Tanaka Y, Holmes S, Dawson VL, Dawson TM, Ross CA, Smith WW.
    Neurobiol Aging; 2007 Nov 05; 28(11):1709-17. PubMed ID: 16978743
    [Abstract] [Full Text] [Related]

  • 9. Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson's disease.
    Wu G, Yan B, Wang X, Feng X, Zhang A, Xu X, Dong H.
    J Neurol Sci; 2008 Aug 15; 271(1-2):168-73. PubMed ID: 18495164
    [Abstract] [Full Text] [Related]

  • 10. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
    Sidhu A, Wersinger C, Vernier P.
    FEBS Lett; 2004 May 07; 565(1-3):1-5. PubMed ID: 15135042
    [Abstract] [Full Text] [Related]

  • 11. Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.
    Paleologou KE, Irvine GB, El-Agnaf OM.
    Biochem Soc Trans; 2005 Nov 07; 33(Pt 5):1106-10. PubMed ID: 16246056
    [Abstract] [Full Text] [Related]

  • 12. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
    Li B, Zhang Y, Yuan Y, Chen N.
    Parkinsonism Relat Disord; 2011 May 07; 17(4):231-5. PubMed ID: 21215675
    [Abstract] [Full Text] [Related]

  • 13. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
    Liu IH, Uversky VN, Munishkina LA, Fink AL, Halfter W, Cole GJ.
    Glycobiology; 2005 Dec 07; 15(12):1320-31. PubMed ID: 16037493
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease.
    Angot E, Brundin P.
    Parkinsonism Relat Disord; 2009 Dec 07; 15 Suppl 3():S143-7. PubMed ID: 20082977
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synucleins and their relationship to Parkinson's disease.
    von Bohlen Und Halbach O.
    Cell Tissue Res; 2004 Oct 07; 318(1):163-74. PubMed ID: 15503152
    [Abstract] [Full Text] [Related]

  • 18. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V, Tan EM, Liebau S, Lenk T, Zettlmeisl H, Schwarz J, Storch A.
    Neurochem Int; 2006 Apr 07; 48(5):329-40. PubMed ID: 16406146
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.